Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)

Market Cap	4.47B
Revenue (ttm)	397.76M
Net Income (ttm)	-286.00M
Shares Out	879.77M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,112,131
Average Volume	23,458,752
Open	5.19
Previous Close	5.33
Day's Range	5.19 - 5.59
52-Week Range	0.72 - 6.36
Beta	0.49
RSI	68.51
Earnings Date	Apr 29, 2025

About SHE:000908

Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company’s principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. In addition, the company provides CDMO/CMO services. The company was founded in 2003 and is headquartered in Shanghai, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2003
• Employees: 572
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000908

Financial Performance

In 2023, SHE:000908's revenue was 656.89 million, a decrease of -21.86% compared to the previous year's 840.66 million. Losses were -215.14 million, 75.5% more than in 2022.